More OncoSil Medical Ltd news
OncoSil Medical LtdASX: OSL

Clarification Statement

Mar 27, 2020 at 3:10 AM EDT · Issued by OncoSil Medical Ltd

Filed with ASX · Mar 27, 2020 at 3:10 AM EDT

On 6ix: 6ix.com/news/clarification-statement-8

Oncosil Medical Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

  • Pause in TradingMar 26, 2020
  • FDA Grants Breakthrough Device DesignationMar 17, 2020
  • CE Mark UpdateNov 18, 2019
  • Positive CE Mark Status ReportOct 31, 2019
  • OncoSil AGM CEO PresentationOct 28, 2019

Later from OncoSil Medical

  • Oncosil breakthrough device receives CE Marking approvalMar 31, 2020
  • Proposed issue of Securities - OSLMay 3, 2020
  • Allotment of Securities under Institutional PlacementMay 7, 2020
  • OncoSil receives Singapore regulatory approvalMay 31, 2020
  • OncoSil files for TGA registrationJul 1, 2020
All OncoSil Medical news releases↗

Follow OncoSil Medical into a list and get an email when it puts out news.

Follow OncoSil Medical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer